Luciana L. Borio

Senior Fellow for Global Health

Subscribe
Profile picture

Expert Bio

Luciana Borio is a senior fellow for global health at the Council on Foreign Relations (CFR). She also is a venture partner at Arch, a venture capital firm that provides seed/early-stage venture capital for technology firms in information technology, life sciences, and physical sciences. Dr. Borio specializes in biodefense, emerging infectious diseases, medical product development, and complex public health emergencies.

Dr. Borio was formerly (2019-2021) the vice president at In-Q-Tel, an independent, non-profit, strategic investment firm that works to identify, adapt, and deliver innovative technology solutions to support the missions of the United States Intelligence Community. She also previously served as director for medical and biodefense preparedness at the National Security Council (2017-2019), where she coordinated the response to the Ebola epidemic in West Africa, efforts to combat antimicrobial resistance, and the development of an Executive Order to modernize America's influenza vaccines. Prior to that, she served as the acting chief scientist of the U.S. Food and Drug Administration (2015-2017), and the assistant commissioner for Counterterrorism Policy of the FDA (2010-2017). Dr. Borio is an adjunct assistant professor of medicine at Johns Hopkins University (2003-present).

Dr. Borio obtained her MD from George Washington University, completed a residency in internal medicine at New York-Presbyterian/Weill Cornell Medical Center, and a combined fellowship in infectious diseases at Johns Hopkins and critical care at the National Institutes of Health. She continues to practice medicine, part-time, at Johns Hopkins.

affiliations

  • ARCH Venture Partners, venture partner
  • CEPI, Scientific Advisory Board, member
  • Eagle Pharmaceuticals, board member
  • Goldman Sachs, consultant
  • Insulet, board member
  • Johns Hopkins University School of Medicine, assistant professor of medicine (part-time)
  • Nuclear Threat Initiative, board member
  • Noblis, board of trustees, member
Clear All
Regions
Topics
Type

Explore More on Public Health Threats and Pandemics

Public Health Threats and Pandemics

Fentanyl and the U.S. Opioid Epidemic
Opioid addiction has become one of the United States’ biggest killers, endangering public health, the economy, and national security. But closing the floodgates on fentanyl poses a significant foreign policy challenge.

Backgrounder by Claire Klobucista and Mariel Ferragamo December 22, 2023

Pharmaceuticals and Vaccines

A Guide to Global COVID-19 Vaccine Efforts
The swift development of effective vaccines against COVID-19 was an unprecedented scientific achievement. But production challenges, vaccine nationalism, and new variants have all presented hurdles.

Backgrounder by Claire Klobucista December 5, 2022

Health

What Does the CDC Do?
The federal agency has a broad mandate to protect Americans’ health and an expansive global reach. But the COVID-19 pandemic has been one of its most daunting challenges.

Backgrounder by Claire Klobucista August 24, 2022

Top Stories on CFR

NATO (North Atlantic Treaty Organization)

Reverberations From Ukraine
The war in Ukraine marks a new era of instability in Europe. Countering Russia’s efforts will require a stronger, more coordinated NATO.

Report by Andrea Kendall-Taylor June 12, 2024 Center for Preventive Action

China

How the United States Can Effectively Pivot to Asia
After the rise of Chinese power during the 2010s and failed U.S. policies in the Indo-Pacific, the United States should renew the Pivot to Asia and place the region at the center of its grand strategy.*

Expert Brief by Robert D. Blackwill and Richard Fontaine June 11, 2024 Asia Program

France

How Will the EU Elections Results Change Europe?
Far-right advances in the European Parliament elections have destabilized politics in France, a longstanding pillar of the European Union, and highlighted fault lines in the bloc.

In Brief by Liana Fix June 10, 2024